66247-84-5

Usage

Uses

(1H-Imidazol-4-yl)methanamine, HCl

Upstream product

• 57090-90-1 1(H)-imidazole-4⁽⁵⁾-carbaldehyde oxime 
• 3034-50-2 4⁽⁵⁾formylimidazole 
• 1225653-08-6 piperidin-1-yl-(1-trityl-1H-imidazol-4-yl-methylene)amine 
• 191104-34-4 4-azidomethyl-1H-1-triphenylmethylimidazole 

Downstream Products

• 1225653-10-0 methyl (S)-2-[3-(1H-imidazol-4-yl-methyl)ureido]-3-(4-methoxyphenyl)-propanoate 
• 1093660-15-1 N₆-benzoyl-5'-O-(4,4'-dimethoxytrityl)-8-[(4-imidazolyl)methylamino]-2'-deoxyadenosine 

Relevant academic research and scientific papers

MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS

The present invention relates to novel melanocortin receptor modulators corresponding to the general formula (I) to compositions containing them, to the process for preparing them and to their use in pharmaceutical or cosmetic compositions.

SUBSTITUTED BIARYLS, PROCESS FOR THEIR MANUFACTURE AND USE THEREOF AS MEDICAMENTS

The present invention relates to compounds of general formula (I) wherein A, B, L, R1, R2, R3a and R3b are defined as in the specification, the tautomers, the enantiomers, the diastereomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable properties.

TRANSITION-METAL BINDING SITE OF BLEOMYCIN. SIGNIFICANCE OF THE β-AMINOALANINAMIDE APPENDAGE IN REGULATING OXYGEN ACTIVATION

A synthetic model study on the iron-binding site of bleomycin demonstrated that the dioxygen-activating properties of ligands largely depend on the characteristics of functional groups contained in the β-aminoalaninamide moiety.